Mandate

Nextmune acquires operations from Oystershell

January 05, 2017

Vinge has advised Nextmune Holding B.V., primarily owned by Fidelio Capital and Premune, in connection with the acquisition of Oystershell NV’s operations pertaining to animal health products.

Vinge’s team consisted of, among others, partner Jonas Bergström and associate Gustav Tengblad.

Related

Vinge has advised Oncopeptides in connection with a directed share issue

Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026